Variant report
Variant | esv2132531 |
---|---|
Chromosome Location | chr10:824190-824587 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:778218..778962-chr10:824579..825446,5 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554837679 | chr10:824190-824191 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs528563905 | chr10:824202-824203 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs113001453 | chr10:824211-824212 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs5027683 | chr10:824256-824257 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs533095113 | chr10:824282-824283 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549616005 | chr10:824292-824293 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs569522599 | chr10:824295-824296 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs181858237 | chr10:824309-824310 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548746717 | chr10:824312-824313 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564924588 | chr10:824325-824326 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs2892158 | chr10:824342-824343 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs2386866 | chr10:824356-824357 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113142140 | chr10:824366-824367 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112704652 | chr10:824369-824370 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186875092 | chr10:824416-824417 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs143537364 | chr10:824430-824431 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs576729977 | chr10:824437-824438 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372241901 | chr10:824438-824439 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs112358966 | chr10:824440-824441 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113174952 | chr10:824443-824444 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543269812 | chr10:824475-824476 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553587732 | chr10:824491-824492 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs146031919 | chr10:824494-824495 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs545453173 | chr10:824500-824501 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565135461 | chr10:824503-824504 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs79604393 | chr10:824505-824506 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs375173582 | chr10:824563-824564 | Enhancers Weak transcription Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 20409316 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Cancer | 21129771 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Wilms tumour | 19047088 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Barakat syndrome | 22470819 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Autism | 18414403 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Breast cancer | 22032731 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 17363583 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21785460 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Breast cancer | 21858162 | CNVD |
Obesity | 19966786 | CNVD |
Aortic dissecting aneurysms | 22263138 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:818400-830600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr10:821800-824600 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr10:822000-825000 | Weak transcription | Stomach Smooth Muscle | stomach |
4 | chr10:822000-825000 | Weak transcription | NH-A | brain |
5 | chr10:822000-825400 | Weak transcription | Osteobl | bone |
6 | chr10:822000-830400 | Weak transcription | Esophagus | oesophagus |
7 | chr10:822800-825400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr10:823200-824400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr10:824000-825200 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
10 | chr10:824400-825200 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |